Baljevic, Muhamed http://orcid.org/0000-0002-0630-8458
Sengsayadeth, Salyka
Article History
Received: 27 December 2023
Revised: 2 January 2024
Accepted: 9 January 2024
First Online: 23 January 2024
Competing interests
: Muhamed Baljevic Consultancy: AbbVie, Pfizer. Advisory Boards: Janssen Biotech, BMS/Celgene, Sanofi-Genzyme. IRCs: Parexel. Salyka Sengsayadeth None.
Free to read: This content has been made available to all.